These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8632711)

  • 1. Comparative dopaminergic and muscarinic antagonist activity of clozapine and haloperidol.
    Sethy VH; Ellerbrock BR; Wu H
    Life Sci; 1996; 58(7):585-90. PubMed ID: 8632711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
    Jackson DM; Mohell N; Bengtsson A; Malmberg A
    Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo actions of clozapine and haloperidol on the turnover rate of acetylcholine in rat striatum.
    Racagni G; Cheney DL; Trabucchi M; Costa E
    J Pharmacol Exp Ther; 1976 Feb; 196(2):323-32. PubMed ID: 943521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The receptor mechanisms underlying the disruptive effects of haloperidol and clozapine on rat maternal behavior: a double dissociation between dopamine D(2) and 5-HT(2A/2C) receptors.
    Zhao C; Li M
    Pharmacol Biochem Behav; 2009 Oct; 93(4):433-42. PubMed ID: 19539643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
    Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2002 Jun; 939(1-2):34-42. PubMed ID: 12020849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
    Gray AM; Connick JH
    Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged treatment with haloperidol and clozapine in the rat: differential effects on spontaneous and theophylline-induced motor activity.
    Ogren SO; Ferré S; Schwarcz R; Fuxe K
    Neurosci Lett; 1997 Aug; 232(1):21-4. PubMed ID: 9292882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum.
    Rothblat DS; Schneider JS
    Neurosci Lett; 1997 Jun; 228(2):119-22. PubMed ID: 9209113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR; Johnson KM
    J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D2 and D1 dopaminergic activity of 7-OH-DPAT.
    Sethy VH; Ellerbrock BR; Fici GJ; Wu H
    Brain Res; 1996 Sep; 733(1):41-5. PubMed ID: 8891246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
    Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
    Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
    Broderick PA; Piercey MF
    J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of haloperidol and low dose clozapine on the acetylcholine turnover rate in rat forebrain structures.
    Bluth R; Langnickel R
    Biomed Biochim Acta; 1985; 44(10):1531-9. PubMed ID: 4084256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol and clozapine: differential effects on the sensitivity of caudate-putamen neurons to dopamine agonists and cholecystokinin following one month continuous treatment.
    Hu XT; Wang RY
    Brain Res; 1989 May; 486(2):325-33. PubMed ID: 2786442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One year treatment with haloperidol or clozapine fails to alter neostriatal D1- and D2-dopamine receptor sensitivity in the rat.
    Ashby CR; Hitzemann R; Rubinstein JE; Wang RY
    Brain Res; 1989 Jul; 493(1):194-7. PubMed ID: 2570618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine.
    Ellenbroek BA; Artz MT; Cools AR
    Eur J Pharmacol; 1991 Apr; 196(1):103-8. PubMed ID: 1678712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.
    Li M; Sun T; Zhang C; Hu G
    Psychopharmacology (Berl); 2010 Sep; 212(1):45-57. PubMed ID: 20623111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.
    Rivest R; Marsden CA
    Br J Pharmacol; 1991 Sep; 104(1):234-8. PubMed ID: 1786513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential pharmacological profile of striatal and cerebellar dopamine receptors labeled by [3H]quinpirole: identification of a discrete population of putative D3 receptors.
    Levant B; DeSouza EB
    Synapse; 1993 May; 14(1):90-5. PubMed ID: 8099762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.